Business
Tarsus acquires iRenix Medical, adds late-stage ocular antiseptic
Company to initiate a phase 3 trial on IRX-101, an ocular antiseptic alternative to povidone-iodine among retinal patients receiving IVT injections.
Products
Essilor introduces Varilux SHIFT progressive lens with AI
Newest lens is designed with proprietary tech that optimizes the position of the near vision zone to better align with a presbyope’s visual habits.
Pipeline
Provectus and VisiRose patent light-free eye drop for drug-resistant BK
Intellectual property covers topical RBS ophthalmic solution against resistant Gram-positive bacteria without the need for light activation.
Products
Eyes On Eyecare launches retina research-based app
Cited for Retina offers a “PubMed meets Instagram Stories” way for retina specialists to discover, digest, and react to new research shaping their practice.
Research
Is there a link between optometric scope expansion and malpractice risk?
Recent analysis suggests that OD malpractice payments remain relatively uncommon, even in states with expanded procedural authority.
Products
Bausch + Lomb launches new AI-based digital health platform
Orphia will offer pre-surgery cataract education for patients via clinically-validated AI agents.
Pipeline
RegenxBio doses first patient in phase 2b/3 trial for DR
One-time gene therapy continues to move down the pipeline, with presentations on efficacy and safety data expected at ASRS.
Pipeline
OKYO's urcosimod gets FDA nod, moves to global phase 3 trial for NCP
Positive Type D meeting feedback supports topical therapeutic’s continued path toward becoming the first approved treatment for neuropathic corneal pain.
Events
Registration opens for Eyes On Cataract & Refactive
Kicking off Aug 15, virtual event invites ophthalmologists seeking to expand their anterior segment expertise by hearing from world-renowned surgeons while earning CME credits.
Research
Leukemia may appear in RVO prior to diagnosis
Ocular findings linked to leukemia may emerge before systemic symptoms, with retinal vascular changes sometimes serving as an early clinical clue.
Products
FDA initiates nationwide recall of 2.5M prednisolone acetate eye drops
Federal agency warns that Lupin’s generic of the prescription-based Pred Forte may have the presence of a foreign substance in its formulation.
Research
Peer-reviewed study supports Deseyne EDOF daily contact lens for presbyopia
Bruno Vision Care’s FDA-cleared Deseyne lens improved intermediate and near vision while maintaining good distance vision in adults with presbyopia
Pipeline
FDA grants RMAT designation to Emmecell's CED cell therapy
EO2002 is a minimally-invasive allogeneic cultured human corneal endothelial cell therapy intended to replace corneal surgery.
Pipeline
Alcon and RxSight partner to to develop light-adjustable PCIOLs
Non-exclusive deal will combine Alcon’s presbyopia-correcting IOL optical designs with RxSight’s customizable postop light-adjustable technology.
Pipeline
Oculgen enrolls first US patient in global phase 2/3 wet AMD trial
Company aims to utilize 36-week data from the STAT trial to support a BLA following its recent IND approval.
Pipeline
Ollin raises $330M to advance OLN324 in phase 3 studies for DME and wet AMD
Financing to support global clinical development of its bispecific antibody programs following promising phase 1b data readout in a head-to-head against faricimab.
Research
Study identifies stroke risks following ischemic ocular events
Nearly one in four patients had a stroke or transient ischemic attack within a year.
Research
Study suggests ocular history may raise risk for recurrent shingles
Recurrent herpes zoster ophthalmicus clustered in the eight weeks immediately following shingles vaccination, with nearly all cases tied to pre-existing ocular involvement.
Pipeline
Genentech's sBLA for subcutaneous TED therapy receives FDA priority review
Enspryng (satralizumab) has the potential to become the first at-home SC therapy to target the underlying disease with a novel mechanism of action.
Products